MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a study co ...

In a breakthrough investigation published in Nature Medicine found that GLP-1 medicines are not just weight loss drugs, but actually brain reprogramming drugs. The study highlighted how deeply GLP-1 ...